Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward B Neufeld

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Lipid Research|December 13, 2021
Transgelin: a new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screenDiego Lucero, Ozan Dikilitas, Michael M Mendelson, et al.
Plos One|February 27, 2016
Lipoprotein X Causes Renal Disease in LCAT DeficiencyAlice Ossoli, Edward B Neufeld, Seth G Thacker, et al.
Journal of Lipid Research|February 5, 2026
Characterization and response to exercise training of high-density lipoprotein-specific phospholipid effluxEric C Leszczynski, Charles S Schwartz, Kiani J C Jacobs, et al.
The Journal of Clinical Investigation|July 20, 2023
Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular diseaseMasaki Sato, Edward B Neufeld, Martin P Playford, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Lipid Research|December 13, 2021
Transgelin: a new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screenDiego Lucero, Ozan Dikilitas, Michael M Mendelson, et al.
Plos One|February 27, 2016
Lipoprotein X Causes Renal Disease in LCAT DeficiencyAlice Ossoli, Edward B Neufeld, Seth G Thacker, et al.
Journal of Lipid Research|February 5, 2026
Characterization and response to exercise training of high-density lipoprotein-specific phospholipid effluxEric C Leszczynski, Charles S Schwartz, Kiani J C Jacobs, et al.
The Journal of Clinical Investigation|July 20, 2023
Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular diseaseMasaki Sato, Edward B Neufeld, Martin P Playford, et al.
Pageof 4